ArticleClinical journal of the American Society of Nephrology : CJASN2026

Target Trial Emulation: Glucagon-Like Peptide-1 Receptor Agonist, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors for Kidney Outcome Prevention.

Adriana Hung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.